Pharmaceuticals, Biotechnology and Life Sciences
SAN DIEGO, Sept. 23, 2025 (GLOBE NEWSWIRE) — Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on…
Abivax Announces Presentation of Late-Breaking Abstract for Obefazimod from the ABTECT Phase 3 Induction Trials at 2025 United European Gastroenterology…
– Cyclerion Relaunches, Advancing a Phase 2–Ready Program for Millions Living with Treatment-Resistant Depression Through MIT License Agreement – – Webcast to be…
TestoPrime launch a Effective and Best Testosterone Booster Supplement For Men 40 or 50, this is most popular and natural…
Aggregated presentation by day and by marketStatement of transactions in own shares from September 15th to September 19th 2025 Name of…
PALO ALTO, Calif., Sept. 23, 2025 (GLOBE NEWSWIRE) — Semnur Pharmaceuticals, Inc. (“Semnur” or the “Company”) (OTC: SMNR, SMNRW) ,…
BioLegacy’s New Vancouver Hub Drives Innovation in Opioid Crisis Solutions with Unmatched Manufacturing and Research CapabilitiesVANCOUVER, British Columbia, Sept. 23,…
KEY LARGO, Fla., Sept. 23, 2025 (GLOBE NEWSWIRE) — Remedy’s Nutrition®, a trusted natural dietary supplement company since 1972 and…
MELBOURNE, Australia and INDIANAPOLIS, Sept. 24, 2025 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces…
LOS ANGELES, Sept. 23, 2025 (GLOBE NEWSWIRE) — Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for…